Clinical Trial Update: Adjuvant Durvalumab for Esophageal Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update investigating adjuvant durvalumab for esophageal cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Cancer

Drugs mentioned

• Durvalumab (durvalumab)

Snippet

Sponsor: Samsung Medical Center | Conditions: Esophageal Cancer | Phase 2 | Status: UNKNOWN